antiviral medications

Enhanced treatment for hepatitis C cuts prevalence by 80 percent

Yale researchers have found that novel antiviral therapies for hepatitis C could reduce the prevalence of the virus by 80 percent. The findings suggest that hepatitis C virus (HCV) could be eliminated within the U.S. if screening becomes enhanced and treatment is targeted to high-risk populations. Direct-acting antiviral medications have been recently approved for hepatitis ...click here to read more

Hepatitis C treatment successful with combination therapy in those with advanced liver disease

A new study has found that a combination therapy of antiviral medications can be successful in treating hepatitis C in patients with advanced liver disease. Co-principal investigator Michael Curry, M.D., said, “More than half of the patients in the study had failed a prior course of treatment for hepatitis C infection. Our trial showed that ...click here to read more